On October 31, 2018 Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, reported that the company will report third quarter 2018 financial results on Wednesday, November 7, 2018, before the U.S. financial markets open (Press release, Reata Pharmaceuticals, OCT 31, 2018, View Source [SID1234530549]). The company will host a conference call and live audio webcast at 8:00 a.m. ET on Wednesday, November 7, 2018, to discuss the financial results and provide an update on recent progress on its development programs.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Third quarter financial results to be discussed during the call will be included in an earnings press release that will be available on the company’s website shortly before the call at View Source and will be available for 12 months after the call. The conference call can be accessed by dialing (844) 348-3946 (toll-free domestic) or (213) 358-0892 (international) and refer to conference ID 5199828. The audio webcast can be accessed through the Investors & News section of the company’s website at View Source The webcast will be archived and available for replay on the company’s website for at least 90 days after the event.